Polyunsaturated liposomes are antiviral against hepatitis B and C viruses and HIV by decreasing cholesterol levels in infected cells
about
Chronic hepatitis C virus infection and lipoprotein metabolismZika Virus Induced Cellular RemodelingHepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals.Hepatitis C virus life cycle and lipid metabolismInfectious disease. Combating emerging viral threats.Cholesterol depletion of hepatoma cells impairs hepatitis B virus envelopment by altering the topology of the large envelope proteinDevelopment of a liposome microbicide formulation for vaginal delivery of octylglycerol for HIV prevention.Broad-spectrum antivirals against viral fusion.Increased expression of LDL receptor-related protein 1 during human cytomegalovirus infection reduces virion cholesterol and infectivityTheoretical basis of a beneficial role for vitamin D in viral hepatitis.Liposome-mediated delivery of iminosugars enhances efficacy against dengue virus in vivo.A cholesterol tag at the N terminus of the relatively broad-spectrum fusion inhibitory peptide targets an earlier stage of fusion glycoprotein activation and increases the peptide's antiviral potency in vivo.Nanomedicine for Infectious Disease Applications: Innovation towards Broad-Spectrum Treatment of Viral Infections.Liposomes as nanocarriers for anti-HIV therapy.Modulation of Lipid Droplet Metabolism-A Potential Target for Therapeutic Intervention in Flaviviridae Infections.
P2860
Q26784234-E167CFEC-422F-4FC3-876E-1483F556989AQ29365254-15F9A9A7-19DD-421F-BA76-914A5A6A7CEEQ30386551-69333B5B-8595-4C4E-9130-6487A1C3173BQ34792436-5A22C2B9-8E02-4B24-9DBE-4C8734D616D3Q35569547-9C2E5369-462A-41D8-B6FA-0087A19E4A54Q35599384-98921B6F-31B7-436E-8764-8DD40DD99C3BQ35701205-540BB7A4-FB89-4FA1-AA3E-51E0D494E4BEQ36010083-1B72F839-5414-45F5-AB3D-FA117BBEF368Q36119693-7E7CB629-1357-41EE-984D-0A7108BB5E69Q36316676-DD5E2BD9-5B90-48D0-8BD2-31B930D247FCQ36396156-1BFC244F-9A9D-4BAF-AB36-3C0460391C84Q37123271-E756C925-0C6F-4E6D-98D3-54E8490CF03DQ38628767-12EC6F84-B383-4BA5-A859-8F25020A083DQ41195459-5DB8CD70-FB10-4EF6-8DCD-915B6E0F9E22Q47104952-1B3A2CBC-9DAC-4CDD-B3B9-73E19A01B676
P2860
Polyunsaturated liposomes are antiviral against hepatitis B and C viruses and HIV by decreasing cholesterol levels in infected cells
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Polyunsaturated liposomes are ...... terol levels in infected cells
@ast
Polyunsaturated liposomes are ...... terol levels in infected cells
@en
Polyunsaturated liposomes are ...... terol levels in infected cells
@nl
type
label
Polyunsaturated liposomes are ...... terol levels in infected cells
@ast
Polyunsaturated liposomes are ...... terol levels in infected cells
@en
Polyunsaturated liposomes are ...... terol levels in infected cells
@nl
prefLabel
Polyunsaturated liposomes are ...... terol levels in infected cells
@ast
Polyunsaturated liposomes are ...... terol levels in infected cells
@en
Polyunsaturated liposomes are ...... terol levels in infected cells
@nl
P2093
P2860
P356
P1476
Polyunsaturated liposomes are ...... terol levels in infected cells
@en
P2093
Annette Böhmer
Cristina Radulescu
Nicole Zitzmann
Norica Branza Nichita
Raymond A Dwek
Stephanie Pollock
P2860
P304
17176-17181
P356
10.1073/PNAS.1009445107
P407
P577
2010-09-20T00:00:00Z